1-3 of 3
A Durett
Close
Sort by
Journal Articles

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

D. Przepiorka, N. A. Kernan, C. Ippoliti, E. B. Papadopoulos, S. Giralt, I. Khouri, J.-G. Lu, J. Gajewski, A. Durett, K. Cleary, R. Champlin, B. S. Andersson, S. Light
Journal: Blood
Blood (2000) 95 (1): 83–89.
https://doi.org/10.1182/blood.V95.1.83
Published: 2000
Journal Articles

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

M Korbling, YO Huh, A Durett, N Mirza, P Miller, H Engel, P Anderlini, K van Besien, M Andreeff, D Przepiorka
Journal: Blood
Blood (1995) 86 (7): 2842–2848.
https://doi.org/10.1182/blood.V86.7.2842.2842
Published: 1995
Journal Articles

Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional- dose chemotherapy before collection of autologous cells

M Talpaz, H Kantarjian, J Liang, L Calvert, J Hamer, P Tibbits, A Durett, D Claxton, S Giralt, I Khouri
Journal: Blood
Blood (1995) 85 (11): 3257–3263.
https://doi.org/10.1182/blood.V85.11.3257.bloodjournal85113257
Published: 1995